Fidelity Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,064,999
Closed -$1.1B 4556
2019
Q3
$1.1B Sell
11,064,999
-3,969,135
-26% -$377M 0.13% 152
2019
Q2
$1.39B Sell
15,034,134
-1,622,495
-10% -$154M 0.16% 114
2019
Q1
$1.57B Buy
16,656,629
+7,856,422
+89% +$687M 0.19% 102
2018
Q4
$564M Sell
8,800,207
-1,479,051
-14% -$109M 0.08% 252
2018
Q3
$920M Buy
10,279,258
+2,119,257
+26% +$187M 0.1% 179
2018
Q2
$648M Buy
8,160,001
+1,051,528
+15% +$87.3M 0.07% 252
2018
Q1
$634M Sell
7,108,473
-5,401,113
-43% -$518M 0.08% 278
2017
Q4
$1.31B Sell
12,509,586
-4,825,071
-28% -$544M 0.15% 136
2017
Q3
$2.53B Buy
17,334,657
+4,740,190
+38% +$646M 0.31% 53
2017
Q2
$1.64B Buy
12,594,467
+697,250
+6% +$85.4M 0.2% 94
2017
Q1
$1.48B Sell
11,897,217
-5,226,515
-31% -$625M 0.19% 100
2016
Q4
$1.98B Sell
17,123,732
-1,938,592
-10% -$216M 0.26% 74
2016
Q3
$1.99B Sell
19,062,324
-8,688,747
-31% -$940M 0.27% 75
2016
Q2
$2.74B Sell
27,751,071
-1,734,989
-6% -$179M 0.37% 50
2016
Q1
$2.95B Sell
29,486,060
-1,677,940
-5% -$173M 0.41% 43
2015
Q4
$3.73B Sell
31,164,000
-3,010,130
-9% -$348M 0.5% 33
2015
Q3
$3.7B Buy
34,174,130
+1,977,660
+6% +$245M 0.53% 31
2015
Q2
$3.73B Sell
32,196,470
-2,603,109
-7% -$298M 0.48% 30
2015
Q1
$4.01B Buy
34,799,579
+3,539,084
+11% +$423M 0.51% 29
2014
Q4
$3.5B Buy
31,260,495
+14,389,188
+85% +$1.52B 0.46% 34
2014
Q3
$1.6B Buy
16,871,307
+6,940,636
+70% +$626M 0.22% 97
2014
Q2
$853M Buy
9,930,671
+1,942,181
+24% +$148M 0.11% 188
2014
Q1
$558M Sell
7,988,490
-5,976,622
-43% -$473M 0.08% 283
2013
Q4
$1.18B Sell
13,965,112
-3,336,390
-19% -$264M 0.17% 130
2013
Q3
$1.33B Buy
17,301,502
+146,062
+0.9% +$10.2M 0.2% 96
2013
Q2
$1B Buy
+17,155,440
New +$1.03B 0.16% 131

Other funds holding CELG

Fidelity Investments's CELG Position: Q4 2019 in Review

Fidelity Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,064,999 shares — an estimated $1.1B sold.

Fidelity Investments first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.01B in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Fidelity Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Fidelity Investments sold 11,064,999 Celgene Corp shares in Q4 2019, an estimated $1.1B.
  • Fidelity Investments first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Fidelity Investments's Celgene Corp position peaked at $4.01B in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Fidelity Investments's 13F filing for Q4 2019, filed 7 Feb 2020.